Nugene International Inc (NUGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -596 | -6,546 | -487 | -215 | -11,817 |
| Depreciation Amortization | 2,106 | 1,840 | 1,677 | 715 | 1,313 |
| Accounts receivable | -2,322 | -181 | -490 | 0 | -26 |
| Accounts payable and accrued liabilities | 125 | 105 | -119 | 249 | 344 |
| Other Working Capital | -2,114 | 197 | -668 | 249 | 1,971 |
| Other Operating Activity | 2,645 | 4,152 | 609 | -178 | 6,211 |
| Operating Cash Flow | $-156 | $-433 | $522 | $819 | $-2,004 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -5 |
| Purchase Of Investment | -5 | -5 | -24 | 0 | N/A |
| Sale Of Investment | N/A | N/A | 2,000 | 0 | N/A |
| Purchase Sale Intangibles | -346 | -1,409 | -3,455 | -937 | N/A |
| Other Investing Activity | -346 | -1,409 | -3,455 | -937 | 0 |
| Investing Cash Flow | $-351 | $-1,414 | $-1,479 | $-937 | $-5 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 70 | 356 | 130 | 0 | 2,030 |
| Common Stock Issued | 410 | 1,498 | 366 | 0 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 600 | 0 |
| Financing Cash Flow | $480 | $1,854 | $496 | $600 | $2,030 |
| Beginning Cash Position | 31 | 24 | 484 | 2 | 23 |
| End Cash Position | 4 | 31 | 24 | 484 | 45 |
| Net Cash Flow | $-27 | $7 | $-460 | $482 | $22 |
| Free Cash Flow | |||||
| Operating Cash Flow | -156 | -433 | 522 | 819 | -2,004 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -5 |
| Free Cash Flow | -156 | -433 | 522 | 819 | -2,008 |